• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Teleflex Medical

Teleflex Medical
Replies
47
Views
24K
anonymous
Replies
1
Views
1K
anonymous
Replies
13
Views
9K
anonymous
Replies
5
Views
4K
anonymous
Replies
1
Views
4K
anonymous
Replies
1
Views
4K
anonymous
Replies
5
Views
4K
anonymous
Replies
15
Views
11K
anonymous
Replies
0
Views
2K
anonymous
Replies
6
Views
4K
anonymous
Replies
4
Views
7K
anonymous
Replies
32
Views
29K
anonymous
Replies
10
Views
13K
anonymous
Replies
309
Views
121K
anonymous